Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence Posted on 17 February 2017 | by Podymos | Leave a Comment on Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence
